US Tech 100

19,021.60

-3.30%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NYSE
Mallinckrodt Plc (MNK)
Mallinckrodt Plc (MNK) News

MNK

Mallinckrodt (MNK)

Mallinckrodt Plc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:MNK

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
02/27/2025	12:00PM	PR Newswire (US)	Mallinckrodt plc to Report Fourth Quarter and Fiscal Year 2024 Financial Results	NYSE:MNK	Mallinckrodt Plc
12/02/2024	5:45AM	PR Newswire (US)	Mallinckrodt Completes Divestiture of Therakos® Business	NYSE:MNK	Mallinckrodt Plc
11/18/2024	10:00AM	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting	NYSE:MNK	Mallinckrodt Plc
11/14/2024	8:05AM	PR Newswire (US)	Mallinckrodt to Present at Jefferies London Healthcare Conference	NYSE:MNK	Mallinckrodt Plc
11/05/2024	5:45AM	PR Newswire (US)	Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance	NYSE:MNK	Mallinckrodt Plc
10/30/2024	5:50AM	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting	NYSE:MNK	Mallinckrodt Plc
10/29/2024	7:30AM	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at the American College of Gastroenterology (ACG) Annual Meeting	NYSE:MNK	Mallinckrodt Plc
10/26/2024	12:00PM	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024	NYSE:MNK	Mallinckrodt Plc
10/24/2024	5:45AM	PR Newswire (US)	Mallinckrodt to Report Earnings Results for Third Quarter 2024	NYSE:MNK	Mallinckrodt Plc
10/10/2024	5:52AM	PR Newswire (US)	Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. Hospitals	NYSE:MNK	Mallinckrodt Plc
09/17/2024	5:50AM	PR Newswire (US)	Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector	NYSE:MNK	Mallinckrodt Plc
09/03/2024	2:45AM	PR Newswire (US)	THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)	NYSE:MNK	Mallinckrodt Plc
08/06/2024	5:45AM	PR Newswire (US)	Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance	NYSE:MNK	Mallinckrodt Plc
08/06/2024	5:35AM	PR Newswire (US)	Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S.	NYSE:MNK	Mallinckrodt Plc
08/05/2024	6:00AM	PR Newswire (US)	Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million	NYSE:MNK	Mallinckrodt Plc
08/05/2024	6:00AM	PR Newswire (US)	Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million	NYSE:MNK	Mallinckrodt Plc
08/01/2024	7:59AM	PR Newswire (US)	Mallinckrodt to Report Earnings Results for Second Quarter 2024	NYSE:MNK	Mallinckrodt Plc
06/05/2024	5:45AM	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 European Association for the Study of the Liver (EASL) Congress	NYSE:MNK	Mallinckrodt Plc
05/18/2024	6:00AM	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)	NYSE:MNK	Mallinckrodt Plc
05/09/2024	5:45AM	PR Newswire (US)	Mallinckrodt plc Reports First Quarter 2024 Financial Results and Reaffirms Full Year Guidance	NYSE:MNK	Mallinckrodt Plc
03/26/2024	3:01PM	PR Newswire (US)	Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 Guidance	NYSE:MNK	Mallinckrodt Plc
03/11/2024	5:52AM	PR Newswire (US)	Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients	NYSE:MNK	Mallinckrodt Plc
03/04/2024	5:45AM	PR Newswire (US)	Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty Brands	NYSE:MNK	Mallinckrodt Plc
03/01/2024	7:50AM	PR Newswire (US)	Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector	NYSE:MNK	Mallinckrodt Plc
02/02/2024	7:45AM	PR Newswire (US)	Mallinckrodt Announces Board of Directors and Leadership Updates	NYSE:MNK	Mallinckrodt Plc
01/22/2024	5:52AM	PR Newswire (US)	Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress	NYSE:MNK	Mallinckrodt Plc
11/01/2023	5:45AM	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting	NYSE:MNK	Mallinckrodt Plc
10/26/2023	5:53AM	PR Newswire (US)	Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023	NYSE:MNK	Mallinckrodt Plc
08/30/2023	10:54AM	PR Newswire (US)	Mallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing Operations	NYSE:MNK	Mallinckrodt Plc
06/29/2023	5:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:MNK	Mallinckrodt Plc